TriSalus Life Science’s drug delivery shows efficacy against pancreatic cancer

TriSalus Life Science’s drug delivery shows efficacy against pancreatic cancer

WESTMINSTER -- A phase 1b clinical trial shows that administering a concentrated dose of anti-CEA CAR-T cells precisely at the site of a solid tumor by means of TriSalusLife Sciences unique... Read More

Wednesday November 7, 2018 0 comments Tags: Westminster, TriSalus Life Sciences, Sorrento Therapeutics, Mary Szela, Surefire Medical